Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianchang Lin

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Biometrics|September 28, 2012
Semiparametric Bayesian survival analysis using models with log-linear medianJianchang Lin, Debajyoti Sinha, Stuart Lipsitz, et al.
Journal of Biopharmaceutical Statistics|March 29, 2024
Flexible seamless 2-in-1 design with sample size adaptationRunjia Li, Liwen Wu, Rachael Liu, et al.
Statistics in Medicine|February 8, 2025
DOD-SSR: An Adaptive Seamless Phase II/III Design With Dose Optimization Decision and Sample Size Re-estimationMeizi Liu, Jianchang Lin, Yefei Zhang, et al.
Journal of Biopharmaceutical Statistics|June 23, 2022
Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analysesJane Pan, Veronica Bunn, Bradley Hupf, et al.
Journal of Biopharmaceutical Statistics|June 17, 2022
Using surrogate information to improve confirmatory platform trial with sample size re-estimationChengxue Zhong, Qing Li, Liwen Wu, et al.
Clinical Trials (London, England)|July 8, 2025
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomizationYixuan Zhao, Rachael Liu, Jianchang Lin, et al.
Contemporary Clinical Trials|September 17, 2020
Flexible Bayesian subgroup analysis in early and confirmatory trialsVeronica Bunn, Rachael Liu, Junjing Lin, et al.
Journal of Biopharmaceutical Statistics|September 21, 2020
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacyPin Li, Rachael Liu, Jianchang Lin, et al.
Journal of Biopharmaceutical Statistics|August 24, 2022
PMED: Optimal Bayesian Platform Trial Design with Multiple EndpointsTian He, Rachael Liu, Meizi Liu, et al.
Contemporary Clinical Trials|August 28, 2020
Practical considerations of utilizing propensity score methods in clinical development using real-world and historical dataQing Li, Jianchang Lin, Andy Chi, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Biometrics|September 28, 2012
Semiparametric Bayesian survival analysis using models with log-linear medianJianchang Lin, Debajyoti Sinha, Stuart Lipsitz, et al.
Journal of Biopharmaceutical Statistics|March 29, 2024
Flexible seamless 2-in-1 design with sample size adaptationRunjia Li, Liwen Wu, Rachael Liu, et al.
Statistics in Medicine|February 8, 2025
DOD-SSR: An Adaptive Seamless Phase II/III Design With Dose Optimization Decision and Sample Size Re-estimationMeizi Liu, Jianchang Lin, Yefei Zhang, et al.
Journal of Biopharmaceutical Statistics|June 23, 2022
Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analysesJane Pan, Veronica Bunn, Bradley Hupf, et al.
Journal of Biopharmaceutical Statistics|June 17, 2022
Using surrogate information to improve confirmatory platform trial with sample size re-estimationChengxue Zhong, Qing Li, Liwen Wu, et al.
Clinical Trials (London, England)|July 8, 2025
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomizationYixuan Zhao, Rachael Liu, Jianchang Lin, et al.
Contemporary Clinical Trials|September 17, 2020
Flexible Bayesian subgroup analysis in early and confirmatory trialsVeronica Bunn, Rachael Liu, Junjing Lin, et al.
Journal of Biopharmaceutical Statistics|September 21, 2020
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacyPin Li, Rachael Liu, Jianchang Lin, et al.
Journal of Biopharmaceutical Statistics|August 24, 2022
PMED: Optimal Bayesian Platform Trial Design with Multiple EndpointsTian He, Rachael Liu, Meizi Liu, et al.
Contemporary Clinical Trials|August 28, 2020
Practical considerations of utilizing propensity score methods in clinical development using real-world and historical dataQing Li, Jianchang Lin, Andy Chi, et al.
Pageof 8